ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,724.30
-0.33%
S&P ASX All Technology
3,092.70
-1.13%
Brent Oil
82.275
0.00%
US Dollar vs AUD
1.50966
-0.27%
Bitcoin
66,502.70
0.47%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Rain Oncology Inc (RAIN)

  7. Rain Oncology Inc (RAIN) News

RAIN

Rain Oncology (RAIN)

Rain Oncology Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RAIN
DateTimeSourceHeadlineSymbolCompany
05/02/202422:41Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:RAINRain Oncology Inc
31/01/202416:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RAINRain Oncology Inc
27/01/202408:58Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RAINRain Oncology Inc
27/01/202408:56Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RAINRain Oncology Inc
27/01/202408:55Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RAINRain Oncology Inc
27/01/202408:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RAINRain Oncology Inc
27/01/202408:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RAINRain Oncology Inc
27/01/202408:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RAINRain Oncology Inc
27/01/202408:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RAINRain Oncology Inc
27/01/202408:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RAINRain Oncology Inc
27/01/202408:32Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:RAINRain Oncology Inc
27/01/202401:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RAINRain Oncology Inc
27/01/202401:19Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:RAINRain Oncology Inc
27/01/202401:13Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:RAINRain Oncology Inc
23/01/202408:15Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:RAINRain Oncology Inc
20/01/202400:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RAINRain Oncology Inc
17/01/202409:22Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:RAINRain Oncology Inc
17/01/202409:18Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:RAINRain Oncology Inc
04/01/202406:57PR Newswire (US)Kuehn Law Encourages EGLE, ICVX, RAIN, and AYX Investors to Contact Law FirmNASDAQ:RAINRain Oncology Inc
29/12/202312:48Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:RAINRain Oncology Inc
28/12/202301:27Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:RAINRain Oncology Inc
28/12/202301:20Edgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNASDAQ:RAINRain Oncology Inc
14/12/202322:06Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:RAINRain Oncology Inc
14/12/202322:06Edgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:RAINRain Oncology Inc
14/12/202322:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RAINRain Oncology Inc
10/11/202308:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RAINRain Oncology Inc
10/11/202308:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RAINRain Oncology Inc
12/09/202319:45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2023 - (NASDAQ: RAIN)NASDAQ:RAINRain Oncology Inc
06/09/202319:45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2023 - (NASDAQ: RAIN)NASDAQ:RAINRain Oncology Inc
29/08/202319:45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2023 - (NASDAQ: RAIN)NASDAQ:RAINRain Oncology Inc
 Showing the most relevant articles for your search:NASDAQ:RAIN

Your Recent History

NYSE
MRK
Merck
ASX
AMP
AMP
ASX
XFL
S&P ASX 50
NASDAQ
GOOGL
Alphabet
ASX
XTO
S&P ASX 100
FX
EURAUD
Euro vs AUD
ASX
MQG
Macquarie
ASX
XMM
S&P ASX 300 Metals and M...
FX
GBPAUD
Sterling vs AUD
NYSE
XOM
Exxon Mobil
NYSE
KO
Coca Cola
ASX
QBE
QBE Insurance
ASX
WPL
Woodside Petroleum
NYSE
JPM
JP Morgan Chase
NASDAQ
MSFT
Microsoft
FX
AUDCAD
AUD vs CAD
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved